FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044650120> ?p ?o ?g. }

• W3044650120 endingPage "121" @default.
• W3044650120 startingPage "121" @default.
• W3044650120 abstract "(1) Introduction: Drug-related deaths in the UK are at concerning high levels. The unknown content and purity of illicit substances can cause unpredictable adverse effects and thus a public health risk with no sign of abating. On-site drug checking is a public health strategy that has previously been implemented, predominantly in festival settings, but without Home Office licensing. (2) Aims: The aim of this study was to pilot the UK’s first pharmacist-led, Home Office-licensed community drug checking service. (3) Methods: A bespoke protocol incorporating legally, professionally and ethically binding documents was implemented. This free, confidential service ran between February and March 2019, was available to anyone over 18 who were purposefully recruited, gave informed consent and agreed to relinquish their drug sample. Samples were checked on-site within an established Substance Misuse Service (SMS) using a handheld Raman spectrometer to determine likely drug content and adulterants. In parallel, participants completed a questionnaire about their substance use and the drug sample(s) being tested. A pharmacist-led multidisciplinary approach was adopted to discuss the analytical findings. Informed by the results of the analysis and the questionnaire, people who used the service received tailored harm reduction advice. (4) Results and Discussion: The pilot operated for a total of four days over four weeks. Eleven people visited and relinquished a total of thirteen samples. Half of the participants had previously overdosed and were known to the SMS. Seventy per cent were male, all were White British individuals, 30% were employed and two people disclosed visiting from another nearby town. Samples included what was thought to be heroin, synthetic cannabinoids, stimulants, benzodiazepines and LSD and none required activation of the “alerts cascade” process. Most participants drank alcohol regularly and the concomitant use of traditional illicit drugs and prescribed medication (including opioids, anxiolytics and antidepressants) with sedating profiles was common. Given some of the ethical decisions and interpretation of the results, specialist pharmacist involvement was deemed essential. (5) Conclusions: This pilot demonstrated the proof-of-concept that a pharmacist-led Home Office-licensed drug checking service can be successfully implemented in community SMSs." @default.
• W3044650120 created "2020-07-29" @default.
• W3044650120 creator A5075349893 @default.
• W3044650120 creator A5078706372 @default.
• W3044650120 creator A5080313345 @default.
• W3044650120 date "2020-07-25" @default.
• W3044650120 modified "2023-09-26" @default.
• W3044650120 title "Piloting the UK’s First Home-Office-Licensed Pharmacist-Led Drug Checking Service at a Community Substance Misuse Service" @default.
• W3044650120 cites W2015567779 @default.
• W3044650120 cites W2112816030 @default.
• W3044650120 cites W2123415121 @default.
• W3044650120 cites W2127845863 @default.
• W3044650120 cites W2129132816 @default.
• W3044650120 cites W2141809971 @default.
• W3044650120 cites W2156580735 @default.
• W3044650120 cites W2332502203 @default.
• W3044650120 cites W2566806374 @default.
• W3044650120 cites W2585850592 @default.
• W3044650120 cites W2621391128 @default.
• W3044650120 cites W2726002060 @default.
• W3044650120 cites W2742111340 @default.
• W3044650120 cites W2765271185 @default.
• W3044650120 cites W2768101678 @default.
• W3044650120 cites W2780201945 @default.
• W3044650120 cites W2794831541 @default.
• W3044650120 cites W2891321860 @default.
• W3044650120 cites W2896245434 @default.
• W3044650120 cites W2905473168 @default.
• W3044650120 cites W2917135447 @default.
• W3044650120 cites W2950343109 @default.
• W3044650120 cites W2962375637 @default.
• W3044650120 cites W3010485803 @default.
• W3044650120 cites W3015936573 @default.
• W3044650120 doi "https://doi.org/10.3390/bs10080121" @default.
• W3044650120 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7465824" @default.
• W3044650120 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32722508" @default.
• W3044650120 hasPublicationYear "2020" @default.
• W3044650120 type Work @default.
• W3044650120 sameAs 3044650120 @default.
• W3044650120 citedByCount "15" @default.
• W3044650120 countsByYear W30446501202021 @default.
• W3044650120 countsByYear W30446501202022 @default.
• W3044650120 countsByYear W30446501202023 @default.
• W3044650120 crossrefType "journal-article" @default.
• W3044650120 hasAuthorship W3044650120A5075349893 @default.
• W3044650120 hasAuthorship W3044650120A5078706372 @default.
• W3044650120 hasAuthorship W3044650120A5080313345 @default.
• W3044650120 hasBestOaLocation W30446501201 @default.
• W3044650120 hasConcept C104863432 @default.
• W3044650120 hasConcept C138816342 @default.
• W3044650120 hasConcept C144133560 @default.
• W3044650120 hasConcept C159110408 @default.
• W3044650120 hasConcept C162853370 @default.
• W3044650120 hasConcept C2779457091 @default.
• W3044650120 hasConcept C2780378061 @default.
• W3044650120 hasConcept C38652104 @default.
• W3044650120 hasConcept C41008148 @default.
• W3044650120 hasConcept C512399662 @default.
• W3044650120 hasConcept C529928208 @default.
• W3044650120 hasConcept C545542383 @default.
• W3044650120 hasConcept C71745522 @default.
• W3044650120 hasConcept C71924100 @default.
• W3044650120 hasConceptScore W3044650120C104863432 @default.
• W3044650120 hasConceptScore W3044650120C138816342 @default.
• W3044650120 hasConceptScore W3044650120C144133560 @default.
• W3044650120 hasConceptScore W3044650120C159110408 @default.
• W3044650120 hasConceptScore W3044650120C162853370 @default.
• W3044650120 hasConceptScore W3044650120C2779457091 @default.
• W3044650120 hasConceptScore W3044650120C2780378061 @default.
• W3044650120 hasConceptScore W3044650120C38652104 @default.
• W3044650120 hasConceptScore W3044650120C41008148 @default.
• W3044650120 hasConceptScore W3044650120C512399662 @default.
• W3044650120 hasConceptScore W3044650120C529928208 @default.
• W3044650120 hasConceptScore W3044650120C545542383 @default.
• W3044650120 hasConceptScore W3044650120C71745522 @default.
• W3044650120 hasConceptScore W3044650120C71924100 @default.
• W3044650120 hasFunder F4320320665 @default.
• W3044650120 hasIssue "8" @default.
• W3044650120 hasLocation W30446501201 @default.
• W3044650120 hasLocation W30446501202 @default.
• W3044650120 hasLocation W30446501203 @default.
• W3044650120 hasLocation W30446501204 @default.
• W3044650120 hasLocation W30446501205 @default.
• W3044650120 hasOpenAccess W3044650120 @default.
• W3044650120 hasPrimaryLocation W30446501201 @default.
• W3044650120 hasRelatedWork W156124411 @default.
• W3044650120 hasRelatedWork W1759121286 @default.
• W3044650120 hasRelatedWork W2043664864 @default.
• W3044650120 hasRelatedWork W2146591287 @default.
• W3044650120 hasRelatedWork W2329990240 @default.
• W3044650120 hasRelatedWork W2399381189 @default.
• W3044650120 hasRelatedWork W2518701417 @default.
• W3044650120 hasRelatedWork W3210139407 @default.
• W3044650120 hasRelatedWork W4288685138 @default.
• W3044650120 hasRelatedWork W2992221107 @default.
• W3044650120 hasVolume "10" @default.
• W3044650120 isParatext "false" @default.
• W3044650120 isRetracted "false" @default.

• next